ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

FUM Futura Medical Plc

39.70
0.80 (2.06%)
17 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.80 2.06% 39.70 39.15 39.80 39.35 38.85 39.05 315,724 16:35:17
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 3.1M -6.51M -0.0217 -18.04 117.73M
Futura Medical Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker FUM. The last closing price for Futura Medical was 38.90p. Over the last year, Futura Medical shares have traded in a share price range of 24.10p to 67.00p.

Futura Medical currently has 300,712,293 shares in issue. The market capitalisation of Futura Medical is £117.73 million. Futura Medical has a price to earnings ratio (PE ratio) of -18.04.

Futura Medical Share Discussion Threads

Showing 21526 to 21541 of 21550 messages
Chat Pages: 862  861  860  859  858  857  856  855  854  853  852  851  Older
DateSubjectAuthorDiscuss
11/5/2024
11:21
Either MDI was up watching the Northern Lights or he was in Glavey's portakabin 'helping' with the night watchman duties! I mean, who else posts comments on FUM in the early hours of the morning apart from rabid stock bashers?
petroc
09/5/2024
19:35
These are very basic A level accounting points and of no issue whatsoever for anyone who understands how financial accounting works. I took the trouble to explain this to you in more detail a while back so will not do so again :)

So this attempt fails at making any argument that you imply.

Please rest there genuinely - I know how desparate you are but there is a life to live...

takeiteasy
09/5/2024
19:26
Really? So why are upfront payments contract liabilities?

‘upfront milestone payment which is to be recognised as a Contract Liability until satisfaction of the performance obligations’

Or ‘royalties not being recognised in full until it is highly probable that a significant reversal in the amount of cumulative revenue recognised will not occur’

And that ‘Futura will remain Legal Manufacturer’ and therefore can be held ‘responsible’ for all legal claims. Why aren’t any of the distributors accepting the same legal risks if they apparently fully accept Eroxon is not a sham device and the marketing is not misleading any men?

‘Legal manufacturer means the organisation responsible for the design, manufacture, packaging and labelling of a device before it is placed on the market under that organisation's own name’



‘Other variable considerations such as milestone payments and royalties are not recognised in full until it is highly probable that a significant reversal in the amount of cumulative revenue recognised will not occur. In managements opinion, that will be when the Groups customer confirms that the milestone has been met or that a royalty is due’

mdi
09/5/2024
19:18
Who accepts this.

Everyone who is closely allied to the business i.e. management, suppliers and sales network - they are all marketing the firm on this basis.

There is simply no more to discuss on this matter.

Anyway time for me to sign off again.

takeiteasy
09/5/2024
18:56
This is simply so dull - we have had this argument 3 times - I accept the testing the firm has done (and so does everyone else) as a valid proxy for what is required.

Yes, you can endlessly state the regulations but when the firm has done the level of testing it has done then that is more than sufficient given the acceptance from all parties bar a few whining medics ....

You do not accept it - everyone knows you do not. So try another topic to discuss.

takeiteasy
09/5/2024
18:36
approval to sell yes in USA is fine..does not have to mean more than that..you worry endlessly about the wrong issues. it is not a sham device so stop trying to wind everyone up...what you fail to understand is as I have said before everyone knows what you know ...so why repeat yourself 100 times over...
takeiteasy
09/5/2024
18:25
MDI, it's impossible to underestimate you.
petroc
09/5/2024
17:57
‘Men with erectile dysfunction (ED) who were in the placebo arm of clinical trials of phosphodiesterase 5 inhibitors (PDE5Is) had significant improvement in erectile function’



‘the placebo effect in RCT of iPDE5 for ED occurs at a rate as high as 50%’



‘Recent research has shown that the placebo effect is not only similar for medical devices to medical trials; it is considerably larger, the effect of a sham device is almost three times that of an oral placebo’



Placebo Treatment: Don't Eat It, Rub it!

˜indications to suggest that a topical placebo induces stronger effects than an oral placebo’

mdi
09/5/2024
15:40
Of course the FDA is not going to offer any sort of warranty in the small print but that is standard legal practice and not worth jumping and down 100 times over.
takeiteasy
09/5/2024
15:37
Futura Medical Shares Rise After FDA Approves Erectile Dysfunction Treatment
12/06/2023 8:44am
Dow Jones News

Please note the word approves....

takeiteasy
09/5/2024
15:20
Incorrect. Low class Medical devices like Eroxon do not get ‘approved’ by regulators.



‘Consumers may not be aware that, as the FDA explains, ‘Registration and Listing does not denote approval or clearance of a firm or their devices meaning that when you see ‘FDA registered’ or FDA listed’ in advertising it not indicative of the efficacy or safety of the product, no matter how much the marketer would like you to believe otherwise’



Dear Ken James:

‘FDA concludes that this device should be classified into Class II’

Page 3

Please be advised that FDA's decision to grant this De Novo request does not mean that FDA has made a determination that your device complies with other requirements of the FD&C Act or any Federal statutes and regulations administered by other Federal agencies

In

In terms of advertising and promotion, for most over-the-counter medical devices, the FDA and FTC exercise joint regulatory authority over product labelling and advertising. The FDA has primary jurisdiction over labelling for all medical devices and advertising for restricted devices (typically Class III), while FTC has primary jurisdiction over advertising of unrestricted medical devices (Class I and most Class II devices). The FDCA prohibits the distribution or receipt in interstate commerce of a misbranded medical device, which includes a device bearing false or misleading labelling. Claims in device labelling, including product websites, that are outside the scope of the device cleared uses can misbrand, and even adulterate the device, another prohibited act under the FDCA

mdi
09/5/2024
15:13
The regulator has approved it and so has the sales network. End of. No one on the planet apart from a few moaning medics and you has the slightest interest. The more successful eroxon is the less money the medics will make from their fewer client consultations as this allows direct client access to treatment bypassing medics where appropriate- no wonder some medics are not going to be cheerful :)
takeiteasy
09/5/2024
13:51
Yet the fact remains. Med3000 is still unable to support any of its claims or even its speed of onset claims with evidence from any double-blind, randomized, placebo-controlled clinical trial to substantiate any efficacy beyond just using any similar non medicated placebo hydroalcoholic gel. So medical device clearance process of Eroxon was only completed to the ‘flimsy’, ‘least burdensome’ efficacy standard for a low class medical device. It was not completed to a standard to substantiate its ‘clinically proven’ beyond a placebo gel in any double blind study.



‘Its the gold standard in medicine: taking a treatment, and putting it head-to-head against a placebo to confidently declare whether it actually works. But for most medical (including Eroxon) devices, placebo trials have never been done’




Dear Ken James:

Page 3

Please be advised that FDA's decision to grant this De Novo request does not mean that FDA has made a determination that your device complies with other requirements of the FD&C Act or any Federal statutes and regulations administered by other Federal agencies



‘The FTC and the Food and Drug Administration (FDA) share jurisdiction over the marketing of dietary supplements, foods, drugs, devices, and other health-related products’

mdi
09/5/2024
13:48
The question was about a definition of a product - not a research validation processs query. The US regulatory bodies approval process was in 2023 and completed.
takeiteasy
09/5/2024
13:47
Could be also claimed Eroxon is the real ‘cut and past job’ exploiting men with ED?

‘The ingredients in Eroxon® gel ”ethanol,[1] propylene glycol,[2] glycerine (also known as glycerol),[3] carbomer[4]

Costs €28.89 for 1.2ml or the equivalent of €2,407.50 / 100 ml



Aia* stimulating gel


€22,95 for 30ml or the equivalent of €76.50 / 100ml

Our stimulating gel is made of water and glycerin, also the two main components of our neutral lubricant. We have added some extras to the stimulating gel. Propylene glycol is a safe synthetic substance with a moisturizing effect. Alcohol Denat or Denatured Alcohol is also often used in natural cosmetics: it dissolves essential oils in the product and it is used to extract certain extracts from plants. Carbomer is an emulsifier and thickener. It ensures that the gel remains a nice, even substance that spreads nicely.

mdi
09/5/2024
13:39
No answer to the question - just repeat a cut and paste job...
takeiteasy
Chat Pages: 862  861  860  859  858  857  856  855  854  853  852  851  Older